Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839293 · ClinicalTrials.gov registry record · Phase 1
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00839293 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 32 participants.
The verdict
NCT00839293, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Interventions
- DRUG ABT-335
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00839293
The ClinicalTrials.gov registry entry for NCT00839293 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-335 is the first listed.
NCT00839293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00839293 about?
NCT00839293 is a clinical study titled "Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules". The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
What is the current status of trial NCT00839293?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2009-02.
What interventions are being tested in trial NCT00839293?
The interventions under investigation include: ABT-335 (DRUG).
Who is sponsoring clinical trial NCT00839293?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.